Day: June 1, 2020

LiiteVINCIT_1.6_trades

MONTREAL, June 01, 2020 (GLOBE NEWSWIRE) — (CSE: EMER) Emergia Inc. (the “Corporation” or “Emergia”) announced today that it has postponed filing its interim financial statements and management’s discussion and analysis for the period ended March 31, 2020 (collectively, its “Interim Documents“) due to delays caused by coronavirus disease 2019 pandemic (“COVID-19”). Further to its announcement on April 20, 2020, the Corporation continues to postpone the filing its annual financial statements and management’s discussion and analysis for the year ended December 31, 2019 (collectively, its “Annual Documents”) to June 15, 2020.Emergia is relying on the exemption provided by the local blanket orders granted by the provincial securities regulators, permitting the Corporation to extend the filing deadlines of its...

MONTRÉAL, 01 juin 2020 (GLOBE NEWSWIRE) — (CSE: EMER) Émergia Inc. (la « Société » ou « Émergia ») a annoncé aujourd’hui qu’elle a reporté le dépôt de ses états financiers intérimaires et son rapport de gestion pour la période terminée le 31 mars 2020 (collectivement, ses « documents intérimaires ») en raison de retards causés par la pandémie de coronavirus de 2019 (« COVID-19 »). À la suite de son annonce du 20 avril 2020 dernier, la Société continue de reporter le dépôt de ses états financiers annuels et son rapport de gestion pour l’exercice se terminant le 31 décembre 2019 (collectivement, ses « documents annuels ») au 15 juin 2020.Emergia s’appuie sur les dispenses générales accordées par les autorités provinciales en valeurs mobilières, permettant à la Société de prolonger jusqu’à 45 jours le délai...

BEIJING, June 01, 2020 (GLOBE NEWSWIRE) — NIU Technologies (“NIU”, or “the Company”) (NASDAQ: NIU), the world’s leading provider of smart urban mobility solutions, announced that the Company launched a new product G0 via e-commerce platform on May 25 2020, a new entry-level e-bicycle model under Gova series in China market. The Company also updated the latest status of its international retail store expansion.New Product LaunchThe G0 is NIU’s entry level product designed to comply with the New National Standard of Electric Bicycle in China.  G0 is a new addition to our Gova series which was launched in September 2019 as a new product series. The Gova series is targeted at the mid-end e-scooter market, representing good value for money and high quality.  The design language is differentiated in comparison to our main e-scooter lines....

The Company’s Participation as an Exhibitor is Free of Charge and the Company Gains Access to 1,000+ Interested Global Business Buyers NEW YORK, NY, June 01, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences Company, with proprietary CBD & CBG infused chewing gums and edibles product(s) as well as two ongoing Biotechnology initiatives, today announced that it has been invited by Chinese E-Commerce conglomerate Alibaba Group (“Alibaba”) to be an Exhibitor at the Inaugural Alibaba.com U.S. Supplements & Nutrition Online Tradeshow – July 7-10, 2020.  Tauriga has been allocated an exclusive exhibitor spot (free of charge) to showcase its products and capabilities, Access to 1000+ interested Business Buyers looking...

BALTIMORE, June 01, 2020 (GLOBE NEWSWIRE) — WillScot Corporation (“WillScot”) (Nasdaq: WSC), the specialty rental services market leader providing innovative modular space and portable storage solutions across North America, today announced that Brad Soultz, President and Chief Executive Officer, and Tim Boswell, Chief Financial Officer, will host virtual meetings with investors during Deutsche Bank’s 2020 Global Industrials & Materials Summit – VIRTUAL.  The meetings are by appointment only and will take place on Monday, June 8th, 2020.About WillScot CorporationHeadquartered in Baltimore, Maryland, WillScot is the public holding company for the Williams Scotsman family of companies. WillScot trades on the Nasdaq stock exchange under the ticker symbol “WSC,” and is the specialty rental services market...

In accordance with the resolution of the 2020 Annual General Meeting in Kinnevik AB (publ) (“Kinnevik”), a Nomination Committee has been convened comprising members appointed by Kinnevik’s largest shareholders in terms of voting interest.The Nomination Committee comprises Cristina Stenbeck appointed by Verdere S.à r.l. and CMS Sapere Aude Trust, Hugo Stenbeck appointed by Alces Maximus LLC, James Anderson appointed by Baillie Gifford, Anders Oscarsson appointed by AMF Insurance & Funds, Marie Klingspor and Ramsay Brufer appointed by Alecta. Anders Oscarsson has been appointed Committee Chairman.Information about the work of the Nomination Committee can be found on Kinnevik’s website at www.kinnevik.com. Shareholders wishing to submit proposals to the Nomination Committee can do so in writing to agm@kinnevik.com or to the Nomination...

I enlighet med beslutet vid årsstämman 2020 i Kinnevik AB (publ) (”Kinnevik”) har en valberedning sammankallats, bestående av ledamöter utsedda av Kinneviks röstmässigt största aktieägare.Valberedningen består av Cristina Stenbeck utsedd av Verdere S.à r.l. och CMS Sapere Aude Trust, Hugo Stenbeck utsedd av Alces Maximus LLC, James Anderson utsedd av Baillie Gifford, Anders Oscarsson utsedd av AMF Försäkring & Fonder, Marie Klingspor och Ramsay Brufer utsedd av Alecta. Anders Oscarsson har utsetts till ordförande i valberedningen.Information om valberedningens arbete finns på Kinneviks hemsida, www.kinnevik.com. Aktieägare som önskar lämna förslag till valberedningen kan göra det i skrift till agm@kinnevik.com eller till Valberedningen, Kinnevik AB, Box 2094, 103 13 Stockholm.För ytterligare information, besök www.kinnevik.com eller...

SHANGHAI, China, June 01, 2020 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEK: 1877), a China-based biopharmaceutical company specializing in discovery, development and commercialization of novel therapies, and Merck, a world leading science and technology company, today announced their collaboration on a clinical trial program designed to investigate the efficacy and safety of anti-PD-1 mAb toripalimab (TUOYI®) in combination with Cetuximab (Erbitux®) as a treatment for recurrent and/or metastatic squamous cell carcinomas of the head and neck (R/M SCCHN) in China.Head and neck cancer is one of the most common cancer types in China, ranking 7th in terms of incidence and mortality1. Each year, there are more than 135,000 new cases and about 70,000 deaths1. And the vast majority (more than 90%) are squamous cell carcinomas2. Head and...

Westport, CT, June 01, 2020 (GLOBE NEWSWIRE) —Company to provide updates on the initiation of human trials for treatment of adult hospitalized patients with COVID-19Phase II clinical trial will be conducted with merimepodib and remdesivir in multiple sites nationwide with data expected in the third quarter 2020BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”) and its subsidiary, ViralClear Pharmaceuticals, Inc., today announced that it will host a call to discuss the Phase II clinical trials of merimepodib, its broad-spectrum oral anti-viral candidate for the treatment of COVID-19 in adult patients.The format will be a management presentation updating recent developments followed by a Q&A session with select call attendees.Conference Call Details:Date: Tuesday, June 9, 2020Time: 11:00 AM Eastern Time (ET)Dial...